MeSH D018273 - islet cell carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Meitheal Pharmaceuticals | Dacarbazine | Dacarbazine | 1998-08-27 | |||
| Teva | Streptozocin | Zanosar | 1982-05-07 | |||
| Bayer | Dacarbazine | Dtic-dome | 1982-01-01 | |||
| Hospira | Dacarbazine | Dacarbazine | 2001-10-18 | |||
| Hikma Pharmaceuticals | Dacarbazine | Dacarbazine | 2001-06-15 | |||
| Fresenius Kabi | Dacarbazine | Dacarbazine | 1999-08-27 | |||
| APP Pharmaceuticals | Dacarbazine | Dacarbazine | 1986-08-28 |
Clinical Trials
Historical Success Rate
Phase 1
56%5/9
Phase 2
0%0/20
Phase 3
100%2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use